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Abstract: Research in the development of new bioceramics with local drug delivery capability 
for bone regeneration technologies is receiving great interest by the scientiﬁ  c biomedical 
community. Among bioceramics, silica-based ordered mesoporous materials are excellent 
candidates as bone implants due to two main reasons: ﬁ  rst, the bioactive behavior of such 
materials in contact with simulated body ﬂ  uids, ie, a carbonate hydroxyapatite similar to the 
mineral phase of bone is formed onto the materials surfaces. Second, their capability of acting 
as delivery systems of a large variety of biologically active molecules, including drugs to treat 
bone infection, inﬂ  ammation or diseases, and molecules that promote bone tissue regeneration, 
such as peptides, proteins, growth factors, and other osteogenic agents. The recent chemical and 
technological advances in the nanometer scale has allowed the design of mesoporous silicas 
with tailored structural and textural properties aimed at achieving a better control over molecule 
loading and release kinetics. Moreover organic modiﬁ  cation of mesoporous silica walls has been 
revealed as a key strategy to modulate molecule adsorption and delivery rates.
Keywords: silica-based ordered mesoporous materials, controlled delivery systems, bone 
tissue regeneration
Introduction
The biomedical community has traditionally used two types of ceramic implants for 
bone tissue regeneration technologies: inert materials such as alumina, zirconia, and 
carbon (Hulber 1993; Wise et al 1995) and bioactive ceramics (Vallet-Regí 2001a), 
which interact with the physiological environment when implanted leading to their 
integration in the living tissue (Hench 1984; Kokubo et al 1990; Langer et al 1993; 
Hench 1998). Depending on the patient needs, an appropriate ceramic material 
should be selected to manufacture a determined implant. When hard tissues, natural 
composite materials, are aimed, the synthetic approach of these composite materials 
is a way to mimic Nature in the laboratory (Vallet-Regí et al 2006a). In the past few 
years bioactive ceramics like calcium phosphates (Yamamuro et al 1990a), bioactive 
glasses and glass-ceramics (Yamamuro et al 1990b) have been deeply investigated. 
Organic-inorganic hybrid materials have been also widely proposed as good candidates 
in the biomaterials ﬁ  eld because they combine the properties of ceramics and organic 
polymers on the nanometric scale (Tsuru et al 1997; Chen et al 1999; Sanchez et al 
2005; Colilla et al 2006; Vallet-Regí et al 2006a). Star gels have been recently reported 
as alternative materials for bone tissue regeneration because they combine the good 
mechanical properties of certain organic-inorganic hybrids with the bioactivity of 
conventional glasses (Manzano et al 2006; Vallet-Regí et al 2006b). However, much 
research effort has been committed to the investigation of ordered mesoporous silica 
materials in the biomedical ﬁ  eld for two main reasons: their capability to regenerate 
bone tissue (Vallet-Regí et al 2006c, 2006d) combined with their drug delivery 
possibilities (Vallet-Regí et al 2006e, 2007a).International Journal of Nanomedicine 2008:3(4) 404
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When these silica-based ordered mesoporous materials 
are exposed to the physiological environment, a series of 
chemical reactions take place in the material-living tissue 
interface, which lead to the material incorporation into 
the living tissue. Those processes are conﬁ  rmed through 
the nucleation and growth on the bioceramic surface of a 
layer of carbonated hydroxyapatite which is analogous to 
the mineral phase of bone tissues (Vallet-Regí et al 2004a). 
Thus, this type of bioceramics would contribute to bone 
tissue regeneration. Recently, much research effort has been 
devoted to the design of mesoporous matrices with appropri-
ated structural, textural and chemical properties in order to 
accelerate the formation of the apatite-like layer (Izquierdo-
Barba et al 2005a; Vallet-Regí et al 2005).
The open texture and outstanding textural properties of 
mesoporous materials have inspired the usage of this type 
of materials as controlled delivery systems of biologically 
active molecules (Vallet-Regí et al 2001b). In fact, their high 
pore volume permits to host a large amount of a determined 
biologically active molecule. Also their ordered pore network 
allows a ﬁ  ne control of the molecule load and release kinetics. 
Since molecules adsorption into the mesopores is a surface 
phenomenon, their high surface area will also favor the adsorp-
tion of a large amount of molecules into their mesopores. And 
the last, but no the least, is the possibility of functionalizing 
the silanol-containing surface with a selected organic group 
depending on the molecule to be adsorbed to allow a better 
control over molecule loading and release.
This double perspective of the mesoporous materials, 
tissue regeneration and drug delivery, has promoted the 
research of these materials for biomedical applications in 
the last few years (Vallet-Regí et al 2008; Izquierdo-Barba 
et al 2008). In fact, the outstanding properties of silica-based 
ordered mesoporous materials make them suitable to be used 
as starting materials for the further design of scaffolds for 
bone tissue engineering. The regular repeating mesoporous 
structures of these silica-based mesoporous materials has 
motivated the adsorption in their pores and subsequent 
release of a large variety of biologically active species such as 
proteins, polypeptides or amino acids. (Yiu et al 2001a; Deere 
et al 2002; Balas et al 2008). Within their possible biomedical 
applications, the case of protein delivery systems using serum 
albumins should be highlighted (Vallet-Regí et al 2007b) 
because these proteins represent one of the major components 
in plasma proteins in humans. Albumin is usually composed 
of a single-chain of 582 amino acids with an average length 
of 10 nm and width of 6 nm (Peters 1995; Sugio et al 1999; 
RCSB 2008). Besides contributing to colloid osmotic blood 
pressure and to the maintenance of the blood pH, the most 
outstanding property of albumin is its ability to bind revers-
ibly an incredible variety of ligands. As a consequence, this 
multifunctional transport protein can be used as carrier or 
reservoir of certain polypeptides with special interest in 
osseous regeneration technologies. Therefore, albumin could 
store, protect, and deliver determined peptides useful for 
bone regeneration to speciﬁ  c places. Moreover, albumins 
are also capable of binding a wide variety of drugs than can 
be delivered to sites of pharmacological action (Carter et al 
1994). Several proteins have been demonstrated to retain their 
functionality without being denatured inside the frameworks 
of silica-based mesoporous materials (Deere et al 2002; 
Cheng et al 2003; Lei et al 2004; Vinu et al 2004; Hartmann 
2005; Katiyar et al 2005; Lee et al 2006; Slowing et al 2007). 
These ﬁ  ndings open up many expectations for the research 
in the adsorption of proteins and other biologically active 
agents into mesoporous silicas.
The adsorption and release characteristics of each porous 
material depend on the physicochemical properties of the 
individual material. Among those properties, it should be 
highlighted the pore diameter, surface area, and pore volume, 
which are critically reviewed here. To achieve this task, it 
is necessary to look into the synthesis conditions of these 
materials, which modulate the physicochemical properties 
of each structure.
Silica-based ordered mesoporous 
materials: General remarks
Silica-based ordered mesoporous materials are synthesized 
using a surfactant templating method (Figure 1) and present 
ordered porous structures with narrow pore size distribu-
tions and some of them with thick walls, which enhance 
their stability. They also show large surface areas and 
large pore volumes. In the early 1990s, Japanese researchers 
(Yanagisawa et al 1990; Inagaki et al 1993) and Mobil 
Corporation research and development scientists (Kresge 
et al 1992) for the ﬁ  rst time reported the synthesis of novel 
periodic mesostructured materials, known as KSW-n and 
M41S family, respectively. These materials are characterized 
by regular arrays of uniform channels, whose dimensions can 
be tailored through the choice of surfactants, additives and 
synthesis conditions in the so-called liquid crystal templating 
mechanism (Beck et al 1992). This process is based on the 
formation of liquid crystals in mixtures of polar solvents 
and surfactants with a non-polar tail group. The formation 
of the liquid crystals is as follows: an increasing amount of 
surfactant molecules is dissolved in an aqueous solution, International Journal of Nanomedicine 2008:3(4) 405
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and when surfactant concentration reaches the critical 
micellar concentration (cmc), the surfactant molecules cluster 
together as micelles. These micelles are formed because the 
hydrophobic tails of the surfactant tend to congregate while 
their hydrophilic heads are procuring protection in water 
(Figure 1). The ﬁ  nal mesostructure of the material will 
depend on the organization of the surfactant molecules into 
the micellar liquid crystals which act as templates for the 
formation of the mesoporous materials. These liquid crystal 
structures depend on the composition and chemical nature 
of the surfactant, and also on the solution mixture condi-
tions, such as surfactant concentration, pH, temperature, the 
presence of additives, etc. In the ﬁ  nal step of the synthetic 
process, once the silica source has condensed around the 
micelles, the surfactant is removed by thermal degradation 
or solvent extraction. This surfactant removal gives rise 
to a network of cavities within the silica framework that 
governs the physicochemical properties of the material. 
Different mesoporous structures have been developed in 
the last few years as a consequence of different modiﬁ  ca-
tions in the synthetic procedure. Among them, the most 
representative and employed materials are MCM-n (Mobil 
Composition of Matter) series (Beck et al 1992; Kresge et al 
1992; Firouzi et al 1997; Zhang et al 1997; Kruk et al 2001; 
Kaneda et al 2002), SBA-n (Santa BArbara materials) series 
(Zhao et al 1998; Ravikovitch et al 2002a, 2002b), MSU-n 
(Michigan State University) series (Bagshaw et al 1995), 
KIT-n (Korean Advanced Institute of Science and Technol-
ogy) series (Ryoo et al 1996), FSM-n (Folded Sheet Material) 
series (Inagaki et al 1996), and AMS-n (Anionic Surfactant 
templated Mesoporous silica) series (Che et al 2003).
In general, silica-based ordered mesoporous materials 
display exceptional properties, such as stable mesoporous 
structure, high surface area (ca 1000 m2/g), large pore 
volume (ca 1 cm3/g), regular and tunable pore size (2–50 nm), 
homogeneous pore morphology, non-toxic and biocompat-
ible behavior, and the possibility of undergoing chemical 
functionalization of pore walls with different organic groups. 
In fact, these inorganic mesoporous materials offer the 
possibility of tuning the chemical properties of their surfaces 
to achieve the desired properties (Hoffmann et al 2006). Two 
major methods of producing functionalized materials have 
been widely used: direct functionalization (Antochshuk et al 
2000), which involves the addition of a trialkoxysilane with 
the selected functional group to the reaction mixture during 
the synthesis process; and post-synthesis functionalization 
(Liu et al 1998), which involves the grafting of the func-
tional group onto the mesoporous material after surfactant 
removal. The direct functionalization method, also known as 
the co-condensation process, presents some advantages like 
Figure 1 Schematic representation of liquid crystal mechanism used to describe the synthesis of silica-based ordered mesoporous materials.International Journal of Nanomedicine 2008:3(4) 406
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a homogeneous dispersion of the functional group, retention 
of the width of the pores of the original framework, and 
the presence of available silanol groups for the adsorbates. 
However, there are some drawbacks like the possibility 
of absence of the functional groups on the surface of the 
material, the possible loss of structure and order of the ﬁ  nal 
structure, and the need of removing the surfactant by solvent 
extraction rather than by calcination, which could lead to an 
incomplete removal of the surfactant molecules. On the other 
hand, the post-synthesis functionalization method presents 
the advantages of retention of the order and structure, and 
the sureness that the functional groups will be located on the 
surface of the pore walls. Though this pathway means an 
extra step in the synthetic process and a reduction in the pore 
diameter, and also it might present a heterogeneous distribu-
tion of the grafted groups, it brings a noticeable change in the 
adsorption characteristics of the silica surface as well as in its 
polarity. The chemical modiﬁ  cation of the pore walls would 
be selected depending on the molecule to be adsorbed, taking 
into account the desired load and release kinetics.
Tailoring the performance 
of mesoporous controlled delivery 
systems
Since 2001, when MCM-41 was proposed for the ﬁ  rst 
time as controlled delivery system (Vallet-Regí et al 
2001b), different mesoporous matrices have been tested 
as delivery systems of several drugs, such as ibuprofen 
(Muñoz et al 2003; Izquierdo-Barba et al 2005b; Manzano 
et al 2008), gentamicin (Xue et al 2004; Doadrio et al 
2006), amoxicillin (Vallet-Regí et al 2004b), erythromycin 
(Izquierdo-Barba et al 2005b; Doadrio et al 2006), 
vancomycin (Yang et al 2005), naproxen (Cavallaro et al 
2004), aspirin (Zeng et al 2005; Zhu et al 2005), diﬂ  unisal 
(Yang et al 2005), captopril (Qu et al 2006), and alendronate 
(Balas et al 2006; Nieto et al 2008). Moreover, mesopo-
rous silicas have been also evaluated as carriers of other 
biologically active species, such as proteins, eg, bovine 
serum albumin [BSA] (Song et al 2005; Vallet-Regí et al 
2007b) and certain amino acids, eg, L-Tryptophan (L-Trp) 
(Balas et al 2008).
The textural properties of silica-based ordered meso-
porous materials seem to govern the loading and release of 
biologically active molecules. Therefore, the inﬂ  uence of 
pore diameter, surface area, and pore volume in molecule 
adsorption and delivery kinetics will be tackled and criti-
cally discussed in the following sections. Moreover, organic 
modiﬁ  cation of silica walls with different functional groups 
to achieve a better control over molecule loading and release 
rate will be also described.
Pore diameter:   An adsorptive size 
selectivity factor and release rate 
modulator
The adsorption of molecules into silica-based ordered meso-
porous materials is a size-selective process and consequently, 
the mesopore diameter determines the size of the molecule 
to be hosted. That is, if the molecule is smaller in size than 
the pore opening, it would have access to the large internal 
surface area and mesoporous volume of the material. On the 
contrary, if not, it would adsorb only on the external surface of 
the material. Usually, the molecule-loading process is carried 
out by soaking the mesoporous carrier in a highly concen-
trated molecule solution. Hence, the adsorptive properties of 
mesoporous materials will determine the amount of adsorbate 
loaded. Therefore, considering that the size of common drugs 
falls into the nanometer scale and that mesopore diameters can 
be tuned from 1.5 nm to several tens of nanometers, it seems 
reasonable to think that mesoporous matrices are able to host 
a wide range of biologically active molecules, ranging from 
small drugs to macromolecules such as large-size proteins.
Pore diameter has been probed to act as a drug-release 
rate modulator. When MCM-41 was reported for the ﬁ  rst 
time as a drug delivery system (Vallet-Regí et al 2001b), 
several cationic surfactants with different chain lengths 
were employed, which led to MCM-41 materials with 
different pore sizes. Thus, the surfactant with the longest 
chain led to the MCM-41 with the largest pore diameter. 
Ibuprofen was chosen as the model drug and drug loading 
and release studies were carried out. Loading tests showed 
that the MCM-41 with the largest pore size released 68% of 
the loaded drug after 24 h into a simulated body ﬂ  uid. On 
the contrary, the MCM-41 with the smallest pore diameter 
released only 55% of the loaded drug after the same time 
period. Further studies conﬁ  rmed the inﬂ  uence of pore size 
on drug delivery rate (Horcajada et al 2004). In this research, 
cationic surfactants with hydrocarbon chains of different 
lengths were used as structure directing agents, leading to 
MCM-41 materials with diverse mesopore diameters, ranging 
from 2.5 nm (short-chain surfactants) to 3.6 nm (long-chain 
surfactants), as displayed in Table 1. The resulting release 
parameters, which are summarized in Table 1, revealed that 
the greater the mesopore diameter, the larger the amount of 
ibuprofen released.
Pore diameter is a limiting factor in molecule adsorption 
when the conﬁ  nement of really large molecules, such as International Journal of Nanomedicine 2008:3(4) 407
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proteins and other biologically active molecules, is targeted. 
Therefore, the adsorption of globular proteins on mesoporous 
MCM-41 (with pore diameters ranging from 2 to 5 nm) has 
been reported in the literature (Deere et al 2002). In general, 
proteins with hydrodynamic dimensions larger than the 
mesopore diameter were adsorbed on the outer surface of 
MCM-41 (Katiyar et al 2005). For this reason, when the 
conﬁ  nement of proteins into mesoporous matrices is targeted, 
large pore mesoporous materials should be employed. The 
group of Prof. Wright (Yiu et al 2001b) investigated the inﬂ  u-
ence of protein dimensions on the adsorption into SBA-15 
mesoporous molecular sieve, whose silica walls were organi-
cally modiﬁ  ed using thiol groups. For this purpose, a series 
of proteins with molecular weights ranging from 12000 to 
76000 u were used to investigate adsorption on SBA-15 
materials. The structures of the employed proteins together 
with their dimensions in nanometers (RCSB 2008) are dis-
played in Figure 2. Further adsorption studies revealed that 
the proteins with the smallest sizes, ie, cytochrome c, lyso-
zyme, myoglobin, and β-lactoglobulin, showed signiﬁ  cant 
adsorption. On the contrary, the proteins with the largest 
sizes, ie, conalbumin, serum albumin and ovalbumin were 
excluded from the internal surfaces of thiol-functionalized 
SBA-15. This fact agrees with the sieving expected from the 
5.1 nm pore size of thiol-functionalized SBA-15 when com-
pared to the proteins dimensions. Moreover, the exclusion 
of ovalbumin (4.0 × 5.0 × 7.0 nm), with dimensions quite 
close to thiol-functionalized SBA-15 matrix, indicates that 
this size selectivity is rigorous and that there are very few 
Table 1 Mesopore diameters of MCM-41 matrices obtained using 
surfactants with different chain lengths and ibuprofen release 
after 24 hours of assay. After 48 hours of test, all ibuprofen was 
released from C12TAB and C16TAB matrices; on the other hand, 
after 55 hours of assay, ibuprofen release was not completed for 
85%C8TAB-15%C10TAB and 70%C8TAB-30%C10TAB
Surfactant* Pore diameter 
(nm)
Ibuprofen released 
after 24 h (%)
85%C8TAB-15%C10TAB 2.5 41
70%C8TAB-30%C10TAB 2.7 42
C12TAB 3.3 49
C16TAB 3.6 61
Abbreviations: C 8TAB, octyltrimethylamonium bromide; C10TAB, decyltri-
methylamonium bromide; C12TAB, dodecyltrimethylamonium bromide; C16TAB, 
hexadecyltrimethylamonium bromide.
Ovalbumin
(4.0 x 5.0 x 7.0 nm)
Serum albumin
(5.0 x 7.0 x 7.0  nm)
Conalbumin
(5.0 x 5.6 x 9.5 nm)
(2.1 x 3.5 x 4.4 nm)
Myoglobin
Lysozyme
(1.9 x 2.5 x 4.3 nm)
β-lactoglobulin
(2.9 x 3.4 x 4.0 nm)
Cytochrome C
(2.6 x 3.2 x 3.3 nm)
5.1 nm
H2C
H2C
SH
CH2
Figure 2 Schematic representation of the structure of different proteins with diverse dimensions (RCSB 2008) compared to thiol-functionalized SBA-15. International Journal of Nanomedicine 2008:3(4) 408
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pores appreciably larger than the average pore size. It should 
be remarked that the maximum amounts of protein loaded, 
expressed as a volume percent of the available internal pore 
volume (5% for β-lactoglobulin, 15% for myoglobin, and 
43% for cytochrome c) showed that the protein molecules 
were adsorbed within the mesopores and not only on the 
external surfaces.
From the above results it can be deduced that when the 
conﬁ  nement of large size proteins is the aim, large pore 
mesoporous matrices are needed. This fact inspired the idea 
of using SBA-15 as a mesoporous carrier employing differ-
ent hydrothermal treatments during the synthesis to wide 
the pore diameter of SBA-15 (Vallet-Regí et al 2007b). 
Hence, pore diameters ranging from 8.2 nm to 11.4 nm were 
obtained for SBA-15 materials submitted to hydrothermal 
treatments periods ranging from 1 to 7 days (Figure 3a). 
These pore dimensions seem suitable to host large-size 
proteins. Moreover, BSA loading dependence on SBA-15 
diameter was observed, as displayed in Figure 3b. Hence, 
the amount of BSA loaded was 15%, 23%, 24%, and 27% 
(weight percentage) for SBA-15 exhibiting pore diameters 
of 8.2, 9.5, 10.5, and 11.4 nm, respectively.
With the aim of promoting host-guest SBA-15-protein 
interaction, an organic modiﬁ  cation of silica surface was 
performed using aminopropyl groups and following the 
post-synthesis method (Vallet-Regí et al 2007b). Thus, the 
amino groups of SBA-15 modiﬁ  ed materials would undergo 
attracting electrostatic interactions with the carboxylic 
fraction of amide groups from the protein. As mentioned 
before, organic functionalization always leads to a decrease 
in the mesopore diameter. The BSA molecule is just on the 
limit of the mesopore dimensions, and thus, after amino-
functionalization the amount of BSA loaded decreased 
compared to unmodiﬁ  ed matrices (see Table in Figure 3c). 
However, the BSA loading on amino-modiﬁ  ed SBA-15 matri-
ces underwent a behavior comparable to unmodiﬁ  ed-matrices 
in terms of loading increment as the pore size increased.
The amino functionalization of SBA-15 had a notice-
able inﬂ  uence on BSA delivery kinetics (Figure 3d). The 
BSA release from pure silica mesopore surfaces essentially 
showed a burst proﬁ  le, where more than 90% of the adsorbed 
protein was released within the initial 24 h of tests. The rest 
of the adsorbed protein was linearly released up to complete 
delivery in 192 h in all tested materials, regardless of the 
hydrothermal treatment carried out for synthesis. However, 
amino-modiﬁ  ed SBA-15 materials showed an incomplete 
release of the protein from the mesopores in all cases. 
This partial protein retention was attributed to the strong 
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attracting interaction of silica walls amine groups with the 
protein. After 192 h, the released protein ranged from 25% 
(SBA-15-7d-NH2) up to 60% (SBA-15-3d-NH2) of the ini-
tially loaded amount of protein. As an illustrative example, 
Figure 3d shows BSA release proﬁ  les of SBA-15 submitted 
to 7 days of hydrothermal treatment.
Therefore, the pore size has been revealed as a key factor 
governing the adsorption of proteins in mesoporous materi-
als. The pore size should be noticeably larger than the protein 
to allow the diffusion of the protein into the mesopores. 
However, once the protein is adsorbed, the ruling factor on 
the release kinetics has been shown to be the organic func-
tionalization, due to the host-guest attracting interactions.
Inﬂ  uence of surface area
The adsorption of biologically active molecules into meso-
porous matrices is governed by the chemical interaction 
between silanol groups covering the silica surface and the 
functional groups of the guest molecule. Therefore, surface 
area is expected to determine the amount of molecules 
conﬁ  ned into the silica matrix. This fact was probed when 
MCM-41 mesoporous matrices exhibiting different surfaces 
areas, SBET, ranging from 768 to 1157 m2/g, which were syn-
thesized using surfactants with diverse length-chains, were 
employed as ibuprofen delivery systems (Horcajada et al 
2004). The amount of ibuprofen loaded was found to depend 
on the surface area, as graphically displayed in Figure 4. As 
expected, there was an increase in ibuprofen loading amount 
with the enlargement in the surface area values.
Surface area inﬂ  uence was also shown when alendronate, 
a potent bisphosphonate used in osteoporosis treatments, was 
conﬁ  ned into MCM-41 and SBA-15 mesoporous matrices 
(Balas et al 2006). Both mesoporous matrices exhibited 
the same structure (2D hexagonal and p6mm symmetry) 
but different surface areas, SBET of 1157 and 719 m2/g for 
MCM-41 and SBA-15, respectively. When both matrices 
were loaded with alendronate under the same conditions, 
the maximum amounts of drug loaded were 14% and 8% 
for MCM-41 and SBA-15, respectively. This fact showed 
the clear dependence of maximum drug load on the matrix 
surface area in agreement with results reported later in the 
literature (Qu et al 2006). MCM-41 and SBA-15 were func-
tionalized using amino groups with the aim of increasing 
the attracting host-guest interactions, and alendronate load-
ing and release studies were carried out (Balas et al 2006). 
The amount of alendronate loaded followed the same trend 
that unmodiﬁ  ed materials, ie MCM-41-NH2 loaded more 
alendronate (37%) than SBA-15-NH2 (22%) as a result of 
the higher surface area of MCM-41 (Table 2). In addition, 
it should be noticed that the amount of alendronate loaded 
in modiﬁ  ed materials was almost 3 times larger than those 
of unmodiﬁ  ed materials. This fact can be explained by the 
stronger attracting interactions between phosphonate groups 
and amino groups of modiﬁ  ed materials compared to the 
weaker interaction taking place between phosphonate groups 
and silanol groups from unmodiﬁ  ed matrices (Figure 5). 
Regarding alendronate release, it should be highlighted that in 
all cases an initial burst effect was observed. This fast release 
of the drug could be due to several reasons: alendronate that 
could be adsorbed in the outer surface of the matrix or by the 
existent alendronate gradient between mesoporous matrix 
and delivery medium. Therefore, after 24 h of assay, 28% of 
the total amount of alendronate adsorbed was delivered from 
MCM-41-NH2, whereas at the same time this percentage was 
58% for unmodiﬁ  ed MCM-41 (Table 2). On the other hand, 
11% of the total alendronate loaded was released after 24 h 
of assay from SBA-15-NH2 matrix, whereas 55% of alen-
dronate loaded was delivered after this time from SBA-15. 
After such burst effect, the alendronate was released to the 
medium in a sustained manner following ﬁ  rst order kinetics 
for unmodiﬁ  ed and modiﬁ  ed MCM-41 materials and zero 
order or linear kinetics for unmodiﬁ  ed and modiﬁ  ed SBA-15 
materials. Moreover, the increase in the total drug delivery 
time in functionalized materials compared with unmodiﬁ  ed 
matrices (Table 2) can be ascribed to the stronger interac-
tions between phosphonate groups from alendronate and 
amino groups covering the pore walls. This interaction led 
to a decrease in the alendronate delivery rate. This work 
evidences that the amount of alendronate adsorbed and drug 
Figure 4 Dependence of ibuprofen loading on surface area of MCM-41 mesoporous 
materials synthesized using diverse cationic surfactants with different length-chains.   The 
surfactants and the percentage employed are also displayed (See footnote on Table 1).
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delivery rate can be controlled by appropriately modifying 
the mesoporous carriers with amino groups. In this sense, 
organic functionalization allows a higher control over drug 
loading and release kinetics.
Thus, surface area was found to be an important factor in 
the loading capacity of these mesoporous materials. It was 
found that the higher the surface area, the higher the drug 
adsorption. This relationship was observed for both unmodi-
ﬁ  ed and functionalized materials.
Inﬂ  uence of pore volume
As previously commented, adsorption of biologically 
active molecules is a surface phenomenon that takes place 
by attracting interactions between the silanol groups in the 
pore walls (or functional groups in the case of functionalized 
materials) and functional groups of the guest molecule. Thus, 
the amount of molecules adsorbed will depend on the pore 
diameter and surface area as the limiting factor. However, 
when the conﬁ  nement of really large molecules is aimed, 
such as large-size and large-volume proteins, pore volume 
seems to play a key role in molecule adsorption.
Recently, in an effort to promote the loading of large 
biomolecules, mesostructured cellular foams (mesocellular 
foams, MCFs) have been employed as host matrices for 
the adsorption of different enzymes and proteins (Han et al 
1999; Zhang et al 2007). The synthesis of MCFs type mate-
rials is carried out by employing triblock copolymers and 
introducing a swelling agent, such as 1,3,5-trimethylbenzene 
(TMB) into the structure directing template (Schmidt-Winkel 
et al 1999). TEM images of MCF compared to MCM-41 and 
Table 2 Alendronate loading and release data from MCM-41 and SBA-15 before and after functionalization with amino groups
Material Surface area, 
SBET (m2/g)
Alendronate 
loaded (%)
Alendronate released 
after 24 h (%)
Total delivery 
time (h)
MCM-41 1157 14 58 72
MCM-41-NH2 782 37 28 264a
SBA-15 719 8 55 264
SBA-15-NH2 385 22 11 264b
Notes: aIncomplete delivery (76%), bIncomplete delivery (69%).
MCM-41
MCM-41-NH2
SBA-15
SBA-15-NH2
0 51 0 15 20 25 30 35 40
Alendronate loading (%)
NH2-functionalized
mesoporous silica
Unmodified
mesoporous silica
Figure 5 Alendronate adsorption on MCM-41 and SBA-15 mesoporous materials before and after functionalization with amino groups.International Journal of Nanomedicine 2008:3(4) 411
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SBA-15 mesoporous materials are displayed in Figure 6. 
The characteristic two-dimensional hexagonal arrays of 
pores of MCM-41 and SBA-15 mesoporous matrices can 
be observed. Moreover, MCF exhibits three-dimensional, 
continuous, ultra-large pore mesoporous structures 
with large spherical cells interconnected by uniform win-
dows (see arrows in Figure 6). N2 adsorption measurements 
revealed that MCM-41 and SBA-15 mesoporous materials 
exhibit type IV isotherms, typical of ordered mesoporous 
materials. The shape of the hysteresis loops points to 
cylindrical mesopores with very narrow pore size distribu-
tions (Figure 6) (Gregg et al 1982). In the case of MCFs, the 
sharp rise in the adsorption/desorption isotherms at relative 
pressures close to 1 points to the existence of large mesopores 
in these materials (Gregg et al 1982). Pore size distributions 
of different mesoporous matrices are also shown in Figure 6. 
The pore diameter of MCM-41 and SBA-15 materials are 
ca 3 and 9 nm, respectively. MCF presents spherical cells of 
ca 28 nm with windows of ca 18. The diameter of spherical 
cells and windows can be modulated by adjusting the amount 
of swelling agents and the synthesis temperature (Schmidt-
Winkel et al 1999). When the conﬁ  nement of large-size 
BSA is targeted, mesoporous matrices exhibiting large pore 
diameters are needed. Thus, SBA-15 and MCF before and 
after functionalization using amino groups where tested as 
delivery systems for BSA. The amount of BSA loaded in 
MCF materials was higher (24%) than in SBA-15 matrices 
(15%), due to the higher pore volume in the former (Table 3). 
It should be highlighted that the surface area is not the 
determinant factor that governs protein adsorption, because 
it exhibits the opposite trend to protein loading (Table 3). 
The amount of BSA loaded after functionalization followed 
the same trend that unmodiﬁ  ed materials, ie, MCF-NH2 
loaded more BSA (27%) than SBA-15-NH2 (10%), as a 
result of the higher pore volume of the former. The increase 
in BSA loading after functionalization of MCF matrix can 
Relative pressure (P/P0)
Relative pressure (P/P0)
Relative pressure (P/P0)
MCM-41
Pore diameter (nm)
Pore diameter (nm)
Pore diameter (nm)
SBA-15
MCF
Adsorption
Desorption
0
0 20 40 60
16
12
8
4
0 5 10 15 20
6
4
2
0
3
0 1 2 3 45 0
0
1
2
3
0.0 0.2 0.4 0.6 0.8 1.0
0.2 0.4 0.6 1.0
0.0
0.0
0.2 0.4 0.6 0.8
0.8
1.0
V
o
l
u
m
e
 
a
d
s
o
r
b
e
d
/
c
m
3
.
g
-
1
 
(
S
T
P
)
V
o
l
u
m
e
 
a
d
s
o
r
b
e
d
/
c
m
3
.
g
-
1
 
(
S
T
P
)
V
o
l
u
m
e
 
a
d
s
o
r
b
e
d
/
c
m
3
.
g
-
1
 
(
S
T
P
)
700
500
300
100
800
700
600
500
400
300
200
100
0
0
MCM-41
1400
1200
1000
800
600
400
200
0
SBA-15
MCF
d
V
/
d
(
l
o
g
 
D
p
)
/
 
c
m
3
.
g
-
1
 
d
V
/
d
(
l
o
g
 
D
p
)
/
 
c
m
3
.
g
-
1
 
d
V
/
d
(
l
o
g
 
D
p
)
/
 
c
m
3
.
g
-
1
 
N2 Adsorption TEM images
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be attributed to the higher attracting electrostatic interactions 
of amino groups with the amide groups of protein. However, 
as it was previously mentioned, organic functionalization 
always leads to a decrease in pore diameter (Table 3). The 
pore diameter of SBA-15 (8.5 nm) is just on the limit of 
BSA size and therefore, after functionalization the pore 
diameter decreased to 6.9 nm and consequently, a decrease 
in the amount of BSA adsorbed was observed. On the other 
hand, organic functionalization with amino groups strongly 
inﬂ  uenced the BSA release kinetics. As it can be observed in 
Figure 7, unmodiﬁ  ed matrices exhibited an initial burst effect 
when almost 60% of the protein was quickly released to the 
delivery medium and then the loaded protein was delivered 
in a controlled fashion. On the contrary, the initial burst in 
amino-modiﬁ  ed matrices was drastically reduced to ca 10%, 
and more than 80% of the loaded BSA was released to the 
medium in a sustained manner. After 24 h of assay, 74% of 
the total BSA loaded in SBA-15 was released to the medium, 
whereas after the same time only 27% was released to the 
medium from SBA-15-NH2 matrix. Moreover, after 24 h 
of delivery test 62% of the loaded BSA was released from 
unmodiﬁ  ed MCF material and this percentage decreased 
to 22% after functionalization with amino groups. This 
research work demonstrates that BSA can be successfully 
adsorbed into large-volume mesoporous matrices exhibiting 
the appropriate pore diameter to allow protein conﬁ  nement. 
Therefore, when the loading of large-size and large-volume 
biologically active molecules is targeted, pore diameter acts 
as the limiting factor and pore volume determines the amount 
of molecule hosted.
Conclusions
In this work it has been shown that available pore volume 
and surface play a key role in the protein loading capacity 
of silica-based ordered mesoporous materials. However, if 
the pore opening is not wide enough, access of the protein 
molecules to much of this surface area and pore volume will 
be restricted. Ideally, if large biomolecules such as certain 
proteins are targeted to be adsorbed in ordered mesoporous 
materials, these matrices should present several charac-
teristics: pore size large enough to allow diffusion into 
the pores, surface area as high as possible to allow a large 
retention percentage, and pore volume as high as possible to 
offer available space into the mesopores to be ﬁ  lled by the 
protein. Recent advances in nanotechnology offer the pos-
sibility of appropriately tailoring the structural and textural 
properties of mesoporous silicas depending on the desired 
application. The outstanding features of silica-based ordered 
mesoporous materials open up promising expectations in the 
Table 3 BSA loading and release data from SBA-15 and MCF materials before and after functionalization with amino groups
Material Pore diameter 
(nm)
Surface area, 
SBET (m2/g)
Pore volume 
(cm3/g)
BSA loaded 
(%)
BSA released 
after 24 h (%)
Total % of BSA 
released after 
264 h of assay
SBA-15 8.5 874 1.1 20 74 93
SBA-15-NH2 6.9 348 0.7 21 27 87
MCF 17.9a 452 1.9 24 62 90
MCF-NH2 15.7a 275 1.6 27 22 86
Notes: aThe pore diameter corresponds to the size of the windows present in the spherical cells.
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biomedical ﬁ  eld because they can be employed as starting 
materials for the further design of scaffolds for bone tissue 
regeneration.
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